These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21263148)

  • 1. Long-term clinical outcomes of patients with primary chronic immune thrombocytopenia: a Danish population-based cohort study.
    Nørgaard M; Jensen AØ; Engebjerg MC; Farkas DK; Thomsen RW; Cha S; Zhao S; Sørensen HT
    Blood; 2011 Mar; 117(13):3514-20. PubMed ID: 21263148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twenty-year mortality of adult patients with primary immune thrombocytopenia: a Danish population-based cohort study.
    Frederiksen H; Maegbaek ML; Nørgaard M
    Br J Haematol; 2014 Jul; 166(2):260-7. PubMed ID: 24690142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Length of stay, hospitalization cost, and in-hospital mortality in US adult inpatients with immune thrombocytopenic purpura, 2006-2012.
    An R; Wang PP
    Vasc Health Risk Manag; 2017; 13():15-21. PubMed ID: 28176930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mental health and use of psychotropic prescription drugs in adult patients with primary immune thrombocytopenia: a nationwide population-based cohort study.
    Mannering N; Hansen DL; Pottegård A; Andersen K; Frederiksen H
    Haematologica; 2024 Sep; 109(9):2944-2954. PubMed ID: 38721747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival in adult patients with chronic primary and secondary immune thrombocytopenia: A population-based study.
    Mannering N; Hansen DL; Pottegård A; Frederiksen H
    Transfusion; 2023 Feb; 63(2):415-426. PubMed ID: 36601709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comorbidities in patients with persistent or chronic immune thrombocytopenia.
    Enger C; Bennett D; Forssen U; Fogarty PF; McAfee AT
    Int J Hematol; 2010 Sep; 92(2):289-95. PubMed ID: 20652840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of immune thrombocytopenic purpura on clinical outcomes in patients with acute myocardial infarction.
    Chehab O; Abdallah N; Kanj A; Pahuja M; Adegbala O; Morsi RZ; Mishra T; Afonso L; Abidov A
    Clin Cardiol; 2020 Jan; 43(1):50-59. PubMed ID: 31710764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Geographic disparities in the care and outcomes in adult chronic immune thrombocytopenia.
    Wall E; Podstawka J; Patterson JM; Bolster L; Goodyear MD; Rydz N; Sun HL
    Thromb Res; 2023 May; 225():87-94. PubMed ID: 37031501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama.
    Watts RG
    Clin Pediatr (Phila); 2004 Oct; 43(8):691-702. PubMed ID: 15494875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer risk in patients with primary immune thrombocytopenia - A Swedish nationwide register study.
    Ekstrand C; Bahmanyar S; Cherif H; Kieler H; Linder M
    Cancer Epidemiol; 2020 Dec; 69():101806. PubMed ID: 32947155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Factors for Immune Thrombocytopenic Purpura Remission after Laparoscopic Splenectomy: A Cohort Study.
    Kwiatkowska A; Radkowiak D; Wysocki M; Torbicz G; Gajewska N; Lasek A; Kulawik J; Budzyński A; Pędziwiatr M
    Medicina (Kaunas); 2019 Apr; 55(4):. PubMed ID: 31003557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune thrombocytopenia and risk of stroke: Evidence from a nationwide population-based cohort study.
    Chen HY; Lee WK; Chang R; Hung YM; Hsu CY; Shih YH; Chen JS
    Int J Stroke; 2023 Apr; 18(4):408-415. PubMed ID: 36073612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of sarcoidosis and immune thrombocytopenia: presentation and outcome in a series of 20 patients.
    Mahévas M; Chiche L; Uzunhan Y; Khellaf M; Morin AS; Le Guenno G; Péronne V; Affo L; Lidove O; Boutboul D; Dion G; Ducroix JP; Papo T; Pacheco Y; Schleinitz N; Michel M; Godeau B; Valeyre D
    Medicine (Baltimore); 2011 Jul; 90(4):269-278. PubMed ID: 21694642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatobiliary laboratory abnormalities among patients with chronic or persistent immune thrombocytopenia (ITP).
    Enger C; Bennett D; Dawson KL; Aivado MA; Theodore D; McAfee AT
    Ann Hepatol; 2011; 10(2):188-95. PubMed ID: 21502681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of diagnosed adult immune thrombocytopenia in the United Kingdom.
    Bennett D; Hodgson ME; Shukla A; Logie JW
    Adv Ther; 2011 Dec; 28(12):1096-104. PubMed ID: 22139790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the immature platelet fraction in the diagnosis and prognosis of childhood immune thrombocytopenia.
    Adly AA; Ragab IA; Ismail EA; Farahat MM
    Platelets; 2015; 26(7):645-50. PubMed ID: 25350586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune thrombocytopenic purpura increased risk of subsequent pancreatitis: A Nationwide population cohort study.
    Wu SC; Lin SF; Fang CW; Tsai IJ; Yang WC
    Sci Rep; 2019 Nov; 9(1):16923. PubMed ID: 31729447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost and mortality associated with hospitalizations in patients with immune thrombocytopenic purpura.
    Danese MD; Lindquist K; Gleeson M; Deuson R; Mikhael J
    Am J Hematol; 2009 Oct; 84(10):631-5. PubMed ID: 19705429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Epidemiology, disease presentation and course of idiopathic thrombocytopenic purpura in Danish children from 1998-2000].
    Kjaersgaard M; Edslev PW; Rosthøj S
    Ugeskr Laeger; 2008 May; 170(22):1922-6. PubMed ID: 18513475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology and Clinical Manifestations of Immune Thrombocytopenia.
    Kohli R; Chaturvedi S
    Hamostaseologie; 2019 Aug; 39(3):238-249. PubMed ID: 30868551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.